New York, New York--(Newsfile Corp. - April 19, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Banco Santander, S.A. (NYSE: SAN) resulting from allegations that Santander may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Santander securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ...

NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Banco Santander, S.A. (NYSE: SAN) resulting from allegations that Santander may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Santander securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Banco Santander, S.A. due to allegations of materially misleading business information issued by the company [1] Group 1: Investigation Details - The investigation is prompted by a Reuters article published on February 27, 2026, which reported on the collapse of UK mortgage provider Market Financial Solutions Ltd, raising concerns about potential losses for banks, including Santander [1] - Following the news, Santander's American Depositary Shares (ADSs) experienced a decline of 4.48% on February 27, 2026, and an additional 3.2% on February 28, 2026 [1] Group 2: Legal Action and Representation - Investors who purchased Santander securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [1] - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in recovering significant amounts for investors [1]

Core Viewpoint - Banco Santander (SAN) shares dropped 12.6% to $11.55 amid unconfirmed trade war news, despite strong fundamentals indicating a different narrative [1] Group 1: Stock Performance - Santander's stock is down 14% since the announcement of a potential US trade halt with Spain [1] - Retail investor sentiment on Reddit has decreased from a quarterly average of 31.6 to a current weekly score of 23.125, indicating bearish sentiment [1] Group 2: Trade War Impact - The selloff was triggered by a viral Reddit post claiming Trump announced a full halt to US trade with Spain, leading to immediate declines in Spanish ADRs, including Santander [1] - The post was marked as "potentially misleading/unconfirmed," reflecting a debate on the credibility of the geopolitical threat [1] Group 3: Financial Performance - Santander reported a record 2025 attributable profit of €14.1 billion, a 12% increase year-over-year [1] - The efficiency ratio improved to 41.2%, the best in over 15 years, and the payments segment saw a 50% profit increase in constant euros [1] - Santander's 2025 EPS of $0.91 was 3.6% below consensus estimates but still represented a 17% year-over-year increase [1] Group 4: Acquisition and Growth Strategy - Santander is pursuing a $12.2 billion acquisition of Webster Financial, which is central to its US growth strategy [1] - If the Webster deal closes on schedule in H2 2026, Santander targets a US RoTE of 18% by 2028 [1] - Analysts have expressed concerns that the trade suspension could stall the acquisition, impacting Santander's growth plans [1]

Core Viewpoint - Sanofi's Board of Directors is proposing the appointment of Christel Heydemann as an independent director at the upcoming Annual General Meeting on April 29, 2026, alongside the renewal of existing mandates for Christophe Babule and Jean-Paul Kress [1][4]. Group 1: Board Composition Changes - Christel Heydemann, currently the CEO of the Orange Group since April 2022, has a diverse background in management, having held various positions at Alcatel and Schneider Electric, which will enhance the Board's expertise [3][4]. - Patrick Kron, an independent director and Chairman of the Nomination, Governance and CSR Committee, will step down at the end of his term during the upcoming Annual General Meeting, after 12 years of service [2][4]. - The Board will maintain a total of 16 members post-appointments, including two employee representatives, achieving gender parity with 57% of women (excluding employee representatives) [4]. Group 2: Strategic Focus - The proposed appointment of Christel Heydemann is aimed at strengthening the diversity of expertise within the Board, which is crucial for supporting Sanofi's next phase of development [4]. - Sanofi is committed to addressing urgent healthcare, environmental, and societal challenges through its innovative pipeline, which is driven by research and development [6].

Core Viewpoint - Banco Santander's acquisition of Webster Financial may encounter significant challenges due to President Trump's threats to halt trade with Spain, potentially leading to delays or the collapse of the $12.3 billion deal [1][3][9]. Group 1: Acquisition Details - The acquisition was announced a month ago, with expectations to close in the second half of the year, later narrowed to a third-quarter closing date by Santander's executive group chair, Ana Botín [2]. - The deal involves a proposed transaction of $12.3 billion, making it the largest bank merger or acquisition announced in 2023 [6]. - The combined entity would have approximately $327 billion in assets, positioning it among the largest regional banks in the U.S. [7]. Group 2: Market Reactions - Following Trump's comments, shares of both Banco Santander and Webster Financial experienced declines, with Santander's shares down about 4% and Webster's down 1.6% [6]. - Analyst Mike Mayo downgraded Webster's stock rating to "underweight," citing increased risks associated with the deal's closure [4]. Group 3: Regulatory Scrutiny - The acquisition requires approval from shareholders and regulators in both the U.S. and Spain, with heightened scrutiny expected due to the foreign nature of the deal [7][10]. - If trade relations deteriorate, it could significantly impact the acquisition process, as noted by analysts [10][11]. Group 4: Strategic Implications - Santander's U.S. operations currently hold $243 billion in assets, including various banking services, and the acquisition would enhance its access to Webster's low-cost deposit base and commercial banking operations [8]. - The deal is seen as a strategic move for Santander to strengthen its presence in the U.S. market, particularly in the Northeast [8][10].

Core Viewpoint - Banco Santander has an exposure of between £200 million ($267 million) and £300 million to Market Financial Solutions (MFS), a UK mortgage lender that recently collapsed due to financial irregularities and mismanagement [1]. Group 1: Company Exposure - Santander's exposure to MFS is secured against a portfolio of mortgages [1]. - The reported exposure of Santander is significantly lower than that of other financial institutions, with Barclays owed £495 million, Elliott Management £200 million, and Apollo Global Management's Atlas SP Partners unit £400 million [1]. Group 2: Industry Context - The collapse of MFS has prompted banks and private credit funds to assess their exposure to the lender amid its administration process [1]. - MFS specialized in complex property-backed loans and sought administration after encountering financial difficulties [1].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Banco Santander, S.A. due to allegations of materially misleading business information issued by the company to the investing public [1] Company Summary - Banco Santander, S.A. is facing scrutiny for potentially misleading business information that may have affected its securities [1] - Shareholders who purchased Santander securities may be entitled to compensation through a contingency fee arrangement, which does not require any out-of-pocket fees or costs [1]

Core Viewpoint - Sanofi has filed an amendment to its "Document d'Enregistrement Universel" which includes the Annual Financial Report and updates on corporate governance as per French law [1]. Group 1: Company Information - Sanofi is an R&D driven, AI-powered biopharma company focused on improving lives and fostering growth through innovative medicines and vaccines [3]. - The company aims to address urgent healthcare, environmental, and societal challenges, guided by a commitment to scientific progress [3]. - Sanofi is publicly listed on EURONEXT under the ticker SAN and on NASDAQ as SNY [3]. Group 2: Regulatory Filing - The amendment to the Annual Financial Report has been submitted to the French market regulator, Autorité des marchés financiers (AMF) [1]. - The updated report includes significant additions related to corporate governance [1]. Group 3: Accessibility of Information - The amended document is accessible on Sanofi's official website and the AMF's website [2].

Core Viewpoint - Santander's $12.2 billion acquisition of Webster Financial may face delays due to President Trump's suspension of trade with Spain, according to Wells Fargo analyst Mike Mayo [1] Group 1: Acquisition Details - The acquisition aims to position Santander among the top 10 retail and commercial banks in the U.S. [1] - If completed, the deal would result in a combined U.S. balance sheet of approximately $327 billion in assets for Santander [1] Group 2: Market Reactions - Following the news, Webster's shares fell by 3.2% in late afternoon trading [1] - Santander's shares closed more than 6% lower as a result of the potential deal complications [1] Group 3: Analyst Insights - Analyst Mike Mayo downgraded Webster's stock to underweight, citing increased hurdles for regulatory approval due to trade tensions [1] - Mayo noted that a potential denial of the acquisition could lead to other banks pursuing Webster, potentially reducing the deal price by 10% [1]